2000 Fiscal Year Final Research Report Summary
Structural analysis and molecular modeling of high affinity binding and activation of β1-adrenergic receptor
| Project/Area Number |
11672210
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
医薬分子機能学
|
|---|
| Research Institution | University of Tokyo |
|---|
Principal Investigator |
KUROSE Hitoshi University of Tokyo, Graduate School of Pharmaceutical Sciences, Associate Professor, 大学院・薬学系研究科, 助教授 (10183039)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Keywords | β1-adrenergic receptor / transmembrane region / selective agonist / (-)-RO-363 / constitutively active receptor / structure of ligand |
|---|
| Research Abstract |
(-)-RO363 is one of the β_1-selective agonists, and the affinity of (-)-RO363 for β_1AR is about 100-fold and 3000-fold higher than for β_2AR and β_3AR, respectively. Therefore, (-)-RO363 can be used as a tool to examine the binding site of β_1AR and a role in receptor activation by β_1-selective agonists. We made chimeric β_1/β_2ARs and Ala-substituted β_1ARs, and found several key amino acids responsible for β_1-selective binding of (-)-RO363 (Leu^<110> and Thr^<117> in the second transmembrane domain (TMD 2), and Phe^<359> in TMD 7). To analyze a role of these amino acids in the activation step, we made several mutants of a constitutively active (CA-) β_1AR with Ala substitution of the key amino acids responsible for β_1-selective binding. The degree of decrease in the affinity of CA-β_1AR for (-)-RO363 was essentially the same as that of wild type β_1AR when mutated at Leu^<110> and Thr^<117>. However, the affinity was decreased in Ala-substituted mutant of Phe^<359> compared to that of wild type β_1AR.Therefore, we concluded that Phe^<359> may be required for a conformational change of β_1AR induced by binding of (-)-RO363, and Leu^<110> and Thr^<117> may be necessary for the initial binding of (-)-RO363 with high affinity and Phe^<359> interacts with the N-substituent of (-)-RO363. Based on these results, we built a three-dimensional model of the binding domain for (-)-RO363. The model indicated that TMD 2 and TMD 7 of β_1AR form a binding pocket ; the methoxy phenyl group of N-substituent of (-)-RO363 seems to locate within the cavity surrounded by Leu^<110>, Thr^<117>, and Phe^<359>, and Leu^<110> and Phe^<359> interact with the phenyl ring of (-)-RO363, whereas Thr^<117> forms hydrogen bond with the methoxy group of (-)-RO363. These results can be also used for better drug design.
|
